Patriot Battery Metals Inc. (ASX:PMT) Launches 2025 Winter Drill Program
Patriot Battery Metals Inc. (ASX:PMT) launches its 2025 winter drill program at Shaakichiuwaanaan Property, targeting 15,000m over four months.
Tag: Industry-Specific News
CLINUVEL Pharmaceuticals Limited (ASX:CUV) Reports Preliminary CUV052 Study Results
CLINUVEL (ASX:CUV) releases preliminary results from the CUV052 study, supporting SCENESSE®’s safety in adolescent EPP patients.
Smartgroup Corporation Ltd (ASX:SIQ) Secures Monash Health Contract for Salary Packaging
Smartgroup Corporation Ltd (ASX:SIQ) secures a contract with Monash Health to provide salary packaging and novated leasing services for 25,000 employees.
Nagambie Resources (ASX:NAG) Announces Research Findings on Whroo Project
Nagambie Resources (ASX:NAG) reports significant research findings on its Whroo Project, highlighting high-grade antimony and gold assays.
Albion Resources Limited (ASX:ALB) Identifies New Priority Gold Targets
Albion Resources (ASX:ALB) identifies significant new gold targets at Yandal West, highlighting exploration potential and upcoming drilling plans.
Red Metal Limited (ASX:RDM) Confirms Sybella Rare Earth Discovery Continuity
Red Metal Limited (ASX:RDM) confirms the strong continuity of its Sybella rare earth discovery through infill drilling, enhancing resource confidence.
Trek Metals Limited (ASX:TKM) Announces High-Grade Manganese Discovery
Trek Metals Limited (ASX:TKM) announces high-grade manganese discoveries at Pearana Prospect, highlighting strong exploration results and future drill plans.
PYC Therapeutics (ASX:PYC) Receives Approval to Begin Human Trials for PKD Treatment
PYC Therapeutics (ASX:PYC) receives regulatory approval to commence human trials for its PKD drug candidate, PYC-003.
Firetail Resources Limited (ASX:FTL) Uncovers Multiple EM Conductor Targets at Skyline Project
Firetail Resources (ASX:FTL) announces the discovery of multiple EM conductor targets at the Skyline Copper Project, advancing its exploration efforts.
Radiopharm Theranostics (ASX:RAD) Reports Successful Detection of Brain Metastases with RAD 101
Radiopharm Theranostics (ASX:RAD) announces successful clinical trial results for RAD 101 in detecting brain metastases, advancing their oncology portfolio.